JHC
NVS icon

J. Hagan Capital’s Novartis NVS Stock Holding History

J. Hagan Capital’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$472K Hold
3,010
– – 0.22% 49
2026
Q1 		$460K Hold
3,010
– – 0.25% 49
2025
Q4 		$415K Hold
3,010
– – 0.23% 54
2025
Q3 		$386K Hold
3,010
– – 0.23% 60
2025
Q2 		$344K Hold
3,010
– – 0.23% 57
2025
Q1 		$293K Buy
+3,010
New +$320K 0.24% 50

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

J. Hagan Capital's NVS Position: Q2 2026 in Review

J. Hagan Capital held its Novartis (NVS) position steady in Q2 2026 at 3,010 shares worth $472K. The position accounts for 0.22% of the portfolio, ranked #49.

J. Hagan Capital first reported a position in NVS in Q1 2025 and has held it in 6 quarters since. 1,617 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • J. Hagan Capital held 3,010 shares of Novartis worth $472K as of Q2 2026.
  • J. Hagan Capital left its Novartis share count unchanged in Q2 2026.
  • Novartis made up 0.22% of J. Hagan Capital's portfolio in Q2 2026, its #49 holding.
  • J. Hagan Capital first reported a position in Novartis in Q1 2025 and has held it in 6 quarters since.
  • 1,617 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on J. Hagan Capital's 13F filing for Q2 2026, filed 14 Aug 2026.